Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of Gabapentin Enacarbil (HORIZANT) Extended-Release Tablets for the Treatment of Alcohol Use Disorder

Trial Profile

Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of Gabapentin Enacarbil (HORIZANT) Extended-Release Tablets for the Treatment of Alcohol Use Disorder

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2017

At a glance

  • Drugs Gabapentin enacarbil (Primary)
  • Indications Alcoholism
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 03 Aug 2016 Status changed from recruiting to active, no longer recruiting.
    • 05 May 2016 According to a XenoPort media release, over 75% enrolment has been completed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top